Condition: COPD Exacerbation · COPD Exacerbation Acute · Sponsor: Central Denmark Region
The STOP-COPD trial is a randomized, patient-blinded, prehospital clinical trial designed to evaluate the effect of titrated oxygen therapy compared to standard oxygen treatment in patients with suspected acute exacerbation of chronic obstructive pulmonary disease (AECOPD) treated with inhaled bronchodilators. The primary objective is to determine whether a titrated oxygen strategy targeting SpO₂ 88-92% can reduce 30-day mortality compared to the current standard practice using 100% compressed oxygen as a nebulizer driver.
This description comes directly from the study's public registry record.
Martin F Gude, PhD · 0045 25343621 · martgude@rm.dk
Arne Sylvester R Jensen · 22396968 · arjens@rm.dk
Always discuss trial participation with your own doctor first.
| Prehospital Emergency Medical Servises, Central Denmark Region | Aarhus N, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05703919